Atossa Therapeutics Shares to Trade with Stapled CVRs Starting Today

Key Facts

1Atossa Therapeutics common stock will begin trading with one stapled contingent value right (CVR) per share after close of business on October 19, 2026.

Atossa Therapeutics common stock will begin trading with one stapled contingent value right (CVR) per share after the close of business today, October 19, 2026. PR Newswire reported that each outstanding share will have one CVR attached, and they will transfer together as stapled securities under an agreement with VStock Transfer, LLC.

ATOS closed at $2.91 on October 16, 2026, ahead of this corporate action designed to provide shareholders with potential future value based on specific milestones. During that session, the stock reached a high of $2.95 and a low of $2.51.